Furthermore, the finding that phospho-PR target genes are elevated in metastases relative to primary tumours, suggests that these phospho-PR species are transcriptionally active and contribute to aberrant gene expression that is associated with both poor outcome and survival/outgrowth of breast cancer metastatic lesions. The gene discussed is PGR; the disease is breast carcinoma.